NINDS Division of Translation Research announces $190 Million in Somatic Cell Gene Editing (SCGE) Funding Available- Due date April 3

The program has 6 funding announcements:

RFA-RM-18-012 Rodent Testing Centers for Development of Reporter Systems and Evaluation of Somatic Cell Genome Editing Tools (U42 Clinical Trial Not Allowed)

RFA-RM-18-013 Development of Large Animal Reporter Systems for Testing Somatic Cell Genome Editing Tools (U24 Clinical Trial Not Allowed)

RFA-RM-18-015 Development of Cell and Tissue Platforms to Detect Adverse Biological Consequences of Somatic Cell Gene Editing (U01 Clinical Trial Not Allowed)

RFA-RM-18-016 Innovative Technologies to Deliver Genome Editing Machinery to Disease-relevant Cells and Tissues (UG3/UH3 Clinical Trial Not Allowed)

RFA-RM-18-017 Expanding the Human Genome Editing Repertoire (U01 Clinical Trial Not Allowed)

RFA-RM-18-018 Somatic Cell Genome Editing Dissemination and Coordinating Center (U24 Clinical Trial Not Allowed)

More information about all of these announcements can be found here:

https://commonfund.nih.gov/editing/fundingopportunities

The due date for applications is April 3rd.

Please direct all inquiries to:

Chris Boshoff, Ph.D.
National Institute of Neurological Disorders and Stroke (NINDS)
Email: chris.boshoff@nih.gov